• A Chromogenic In Situ Hybridization (CISH) Assay for Detection of HBV RNA, DNA, and cccDNA in Liver Tissue
• A Fluorescent In Situ Hybridization (FISH) Assay for Detection of HBV RNA, DNA, and cccDNA in Cell Culture
• A high functional cure rate was induced by pegylated interferon alpha-2b treatment in postpartum hepatitis B e antigen-negative women with chronic hepatitis B virus infection: an exploratory study
• A liver immune rheostat regulates CD8 T cell immunity in chronic HBV infection
• A Particle Gel Assay for Detection of Intracellular Hepatitis B Virus Subviral Particles in Cultured Cells
• Activating adaptive immunity by bispecific, T-cell engager antibodies bridging infected and immune-effector cells is a promising novel therapy for chronic hepatitis B
• Age of hepatitis B e antigen loss in Aboriginal, Torres Strait Islander and non-Indigenous residents of tropical Australia; implications for clinical care
• An In-Depth Approach to the Associations between MicroRNAs and Viral Load in Patients with Chronic Hepatitis B-A Systematic Review and Meta-Analysis
• Analysis of HBV cccDNA Minichromosome Accessibility by MNase-qPCR and High-Throughput Sequencing
• Analysis of hepatitis B Virus Test results among blood donors in Chongqing, China
• Analysis of host factor networks during hepatitis B virus infection in primary human hepatocytes
• Analysis of N6-Methyladenosine Modification of HBV RNA by Methylated RNA Immunoprecipitation
• Argonaute-2 autoantibodies: a promising biomarker for predicting mortality in HBV-related acute-on-chronic liver failure patients with cirrhosis
• Association of CXCR4 gene expression and promoter methylation with chronic hepatitis B-related fibrosis/cirrhosis
• Association of HLA-DRB1 alleles with status of antibodies to hepatitis B surface and e antigen
• Both middle and large envelope proteins can mediate neutralization of hepatitis B virus infectivity by anti-preS2 antibodies: escape by naturally occurring preS2 deletions
• Characteristics and antiviral treatment eligibility of patients diagnosed with hepatitis B at a teaching hospital in Ghana: Implications for prevention and management
• Circular Chromosome Conformation Capture (4C-Seq) Analysis of HBV-Host Chromosome DNA Interactome
• Clinical guidelines for hepatitis B virus infection in kidney transplant recipients (2023 edition)
• Clinical performance of Circulating HBV RNA and iTACT-HBcrAg Assays in HBeAg-negative and HBsAg-cleared Chronic Hepatitis B Patients
• Comparative Proteomic Analysis of Huh7 Cells Transfected with Sub-Saharan African Hepatitis B Virus (Sub)genotypes Reveals Potential Oncogenic Factors
• Could Hepatitis B Reactivation be Overlooked in Patients with Resolved Hepatitis B Virus Infection and Receiving Immunosuppressive Treatment?
• Data Independent Acquisition Mass Spectrometry Enhanced Personalized Glycosylation Profiling of Haptoglobin in Hepatocellular Carcinoma
• Detection and Quantification of HBV Transcripts by Full-Length 5'RACE-PCR
• Detection of Hepatitis B Virus Covalently Closed Circular DNA and Intermediates in Its Formation
• Detection technology and clinical applications of serum viral products of hepatitis B virus infection
• Diagnostic Significance of Serum Long Noncoding HOX Antisense Intergenic Ribonucleic Acid in Patients with Hepatitis B Virus Related Hepatocellular Carcinoma
• Differential methylation patterns in paternally imprinted gene promoter regions in sperm from hepatitis B virus infected individuals
• Disparities in hepatitis B virus healthcare service access among marginalised poor populations: a mixed-method systematic review
• Editorial: Trajectory of soluble programmed cell death protein-1 and ligand-1 in HBV-infected individuals treated with pegylated interferon-implications for stopping rules and the HBV cure programme
• Editorial: Trajectory of soluble programmed cell death protein-1 and ligand-1 in HBV-infected individuals treated with pegylated interferon-Implications for stopping rules and the HBV cure programme. Authors' reply
• Effectiveness and safety of tenofovir amibufenamide in chronic hepatitis B patients
• Eliminating perinatal transmission of hepatitis B virus: it is time for action
• Etiologies of Persistent Aminotransferase Elevations in Chronic Hepatitis B Patients Treated with Nucleos(t)ide Analogs
• Evaluating the relationship between hepatitis B viral activity and gestational diabetes mellitus: A prospective cohort study
• Evolution and diversity of the hepatitis B virus genome: Clinical implications
• Ex Vivo Fluorescent Labeling of HBV-Specific B Cells in Chronic Hepatitis B Patients
• Field-applicable simultaneous multiplex LAMP assay for screening HBV and HCV co-infection in a single tube
• Functional cure induced by tenofovir alafenamide plus peginterferon-alpha-2b in young children with chronic hepatitis B: a case series study
• Genetic variants of m⁶A modification genes are associated with survival of HBV-related hepatocellular carcinoma
• Hepatic macrophage niche: a bridge between HBV-mediated metabolic changes with intrahepatic inflammation
• Hepatitis B reactivation risk and physician awareness in rheumatological patients receiving anti-tumor necrosis factor-α treatment
• Hepatitis B Virus Covalently Closed Circular DNA Chromatin Immunoprecipitation Assay
• Hepatitis B virus infection, infertility, and assisted reproduction
• Hepatitis B Virus Reactivation after Switch to Cabotegravir/Rilpivirine in Patient with Low Hepatitis B Surface Antibody
• Histological Findings in Antigen E Positive and Negative in Chronic Hepatitis B
• HIV and hepatitis B virus co-infection in Mozambique: Policy review and health professionals' knowledge and practices
• Impact of universal hepatitis B virus (HBV) screening using chemotherapy orders on the HBV reactivation in cancer patients
• In Vitro Enzymatic and Cell Culture-Based Assays for Measuring Activity of HBV Ribonuclease H Inhibitors
• In vivo Hyperpolarized Metabolic Imaging to Monitor the Progression of Hepatitis B Virus (HBV)-Related Hepatitis to Liver Fibrosis
• Incidences of new hepatitis B infection and anti-hepatitis B core-negative occult hepatitis B infection among Japanese blood donors in relation to anti-hepatitis B surface antigen levels
• Integrating bioinformatics and machine learning methods to analyze diagnostic biomarkers for HBV-induced hepatocellular carcinoma
• Letter to the Editor: Effect of pre-transplant viral therapy on post-transplant hepatitis B virus reactivation in patients with hepatitis B-related hepatocellular carcinoma
• Long-term HBV infection of engineered cultures of induced pluripotent stem cell-derived hepatocytes
• Low risk of hepatitis B virus reactivation in membranous nephropathy patients with resolved infection undergoing rituximab-based regimens without antiviral prophylaxis
• MicroRNA levels in patients with chronic hepatitis B virus and HIV coinfection in a high-prevalence setting; KwaZulu-Natal, South Africa
• Modeling and analysis of Hepatitis B dynamics with vaccination and treatment with novel fractional derivative
• Modeling HBV Infection and Therapy in Immunodeficient NOD-Rag1-/-IL2RgammaC-null (NRG) Fumarylacetoacetate Hydrolase (FAH) Knockout Mice with Human Chimeric Liver
• Molecular epidemiology of hepatitis B, hepatitis C, and HIV-1 co-infections in Ethiopia: Implications for disease burden and intervention strategies
• Monocyte Transcriptome in Different Phases of Chronic Hepatitis B Virus Infection Uncovers Potential Functional Roles
• One-Step Reverse Transcriptase qPCR Method for Serum Hepatitis B Virus RNA Quantification
• Optimized Ex Vivo Fluorospot Assay to Measure Multifunctional HBV-Specific T Cell Frequencies in Chronic Hepatitis B Patients
• Peptide-Loaded HLA Class I Tetramer-Associated Magnetic Bead-Based Enrichment of HBV-Specific CD8+ T Cells
• Performance evaluation of the MAGLUMI Hepatitis B virus surface antigen chemiluminescence immunoassay
• Plasma metabolome analysis for predicting antiviral treatment efficacy in chronic hepatitis B: diagnostic biomarkers and therapeutic insights
• Prevalence and factors associated with hepatitis B susceptibility among men who sex with men on HIV pre-exposure prophylaxis in Northeastern Brazil: a cross-sectional study
• Prevalence and Genetic Diversity of Bat Hepatitis B Viruses in Bat Species Living in Gabon
• Prevalence of HBV genotypes among patients attending Moi Teaching and Referral Hospital liver clinic
• Prevalence of hepatitis B virus infection among pregnant women in Africa: A systematic review and meta-analysis
• Prevalence of Hepatitis B virus infection and its determinants among pregnant women in East Africa: Systematic review and Meta-analysis
• Primary Duck Hepatocyte Culture and Duck Hepatitis B Virus Infection Model
• Production and Purification of Adeno-Associated Viral Vectors for the Development of Immune-Competent Mouse Models of Persistent Hepatitis B Virus Replication
• Progress Toward Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Region of the Americas, 2012-2022
• Quantitative HBV Core Antibodies as a Prognostic Marker for HBeAg Seroclearance: A Systematic Review with Meta-Analysis
• Rapid and Reliable Protein-Free HBV DNA Extraction and Sensitive Branched DNA Southern Blot Assay
• RE: Could Hepatitis B Reactivation Be Overlooked in Patients with Resolved HBV Infection and Receiving Immunosuppressive Treatment?
• Reactivation of hepatitis B virus infection - an important aspect of multifaceted problem
• Risk Factors and Nomogram Model for Hepatocellular Carcinoma Development in Chronic Hepatitis B Patients with Low-Level Viremia
• Risk factors related to low-level viraemia in chronic hepatitis B patients receiving entecavir treatment
• Risk of hepatic decompensation from hepatitis B virus reactivation in hematological malignancy treatments
• Risk of hepatitis B virus reactivation in cancer patients undergoing treatment with tyrosine kinase-inhibitors
• Rupestonic Acid Derivative YZH-106 Promotes Lysosomal Degradation of HBV L- and M-HBsAg via Direct Interaction with PreS2 Domain
• S100A8/A9-activated IFNγ⁺ NK cells trigger β-cell necroptosis in hepatitis B virus-associated liver cirrhosis
• SATCAS: A CRISPR/Cas13a-based simultaneous amplification and testing platform for one-pot RNA detection and SNPs distinguish in clinical diagnosis
• Seroprevalence of hepatitis B and C viruses and some possible associated factors among cancer patients at the Oncology Treatment Center, Gondar, Northwest Ethiopia: A cross-sectional study
• Seroprevalence of hepatitis B virus and hepatitis C virus infection among pregnant women attending antenatal care at Guhala Primary Hospital, Northwestern Ethiopia
• SIGIRR suppresses hepatitis B virus X protein-induced chronic inflammation in hepatocytes
• Significant liver histological change is common in HBeAg-positive chronic hepatitis B with normal ALT
• Single-Cell RNA Sequencing Reveals the Spatial Heterogeneity and Functional Alteration of Endothelial Cells in Chronic Hepatitis B Infection
• Social, clinical and biological barriers to hepatitis B virus suppression with nucleos/tide analogue therapy: who is at risk and what should we do about it?
• SOD1 inhibition enhances sorafenib efficacy in HBV-related hepatocellular carcinoma by modulating PI3K/Akt/mTOR pathway and ROS-mediated cell death
• Solamargine acts as an antiviral by interacting to MZF1 and targeting the core promoter of the hepatitis B virus gene
• Stem Cell-Derived Hepatocyte-Like Cells for Hepatitis B Virus Infection
• Surface antigen serocleared hepatitis B virus infection increases the risk of mixed cryoglobulinemia vasculitis in male patients with chronic hepatitis C
• TCR-like bispecific antibodies toward eliminating infected hepatocytes in HBV mouse models
• The Characteristic of HBV Quasispecies Is Related to Occult HBV Infection of Infants Born to Highly Viremic Mothers
• The Impact of Smoking on Long-Term Protection Following Hepatitis B Vaccination: A 24-Year Cohort Study
• The nuclear matrix protein HNRNPU restricts hepatitis B virus transcription by promoting OAS3-based activation of host innate immunity
• The spatial-temporal distribution of hepatitis B virus infection in China,2006-2018
• To B or not to B: how the hepatitis B surveillance case definition can misdirect public health actions